Oncotarget News Article:

Cancer Research Institute, Medical Blog

*Oncotarget Examined:

Oncotarget is an informational journal which can be accessed free of charge. Oncotarget publishes papers on a weekly basis, the papers can be accessed and printed by request.Oncotarget makes information relating to scientific research studies available to other scientists as well as those involved with specific cancer research studies. The journal articles mainly refer to Biomedical science as well as its applications. The majority of articles published through Oncotarget discuss techniques and new breakthroughs in fighting various diseases.Oncotarget articles help all those within the scientific field to gain new insight and knowledge as well as helping these professionals contribute something that can help cure and treat life threatening diseases. Life without disease is what Oncotarget continually brings to the forefront.

*Current Articles of Interest:

The articles published by Oncotarget are of particular use to those devoted to Oncology research. Cancer research and treatment has advanced to a significant degree over the past four decades. However, until a cure for cancer is discovered researchers feel they still have a great deal more work to do.Recent journal articles published by Oncotarget include “Genes & Cancer, “The Aging Process”, as well as “Issues Concerning Oncoscience”. Genes & Cancer is an informational article which discusses in depth the link between certain genes and the development of cancer. We have known for decades that hereditary factors contribute to many cancers.

The article “The Aging Process” discusses how our bodies age and the effect that the aging process has on our external and internal bodies. Discussion about how our internal organs begin to slow down as the years go by. Also, how older individuals are more susceptible to disease and infection.Articles soon to be published on Oncotarget include “Lung Cancer & Tumor Growth”. Lung Cancer and growth of lug tumors will be discussed within this article. In addition, new cancer drugs that do resist lung tumors will also be a topic of discussion.Finally, Oncotarget is quite informational and it can serve as a research and study source for scientists. All information is updated weekly and reference guides can be obtained upon request.

Omar Boraie Helping Put Smile to Cancer Patients

Cancer Research Institute

Cancer is becoming one of the most common diseases that is affecting people from all walks of life. Everybody is affected, and its effects are devastating especially to the friends and family of the individual suffering from it. Hospitals and research centers are working their socks off to come up with a cancer cure.

The research for getting cancer treatment is overly expensive and mainly relies on donors to assist in the funding. Many donors are setting up cancer foundations to help research or offer care to cancer patients. Philanthropy has been vital in helping the cancer patients who cannot afford the expensive cancer treatment like chemotherapy.

Omar Boraie is a philanthropist who is all about humanity. He has been at the forefront of funding cancer research in educational institutions. It’s hard to come by people who are in charity work like Omar. Mr Boraie has been one of the major funders of groundbreaking cancer research being carried out by Rutgers Cancer Institute of New Jersey.

According to Patch.com, the Omar Boraie Chair in Genomic Science got recently established. These chairs represent the person commitment to an academic discipline by spurring it to the highest level. Mr Boraie, a New Brunswick developer, made a pledge of $1.5 as part of 18 chair challenge aimed at getting funding from donors.

The field of Genomic Science is working on transforming the medical professional’s approach to cancer diagnosis and treatment. Research is done to come up with the best analysis and treatment of cancer to get the best outcome when treating it. The government has been of full support to similar approach a sentiment that was taken up by President Obama during the launch of a national precision medicine initiative. The initiative is all about getting a cure for cancer and other diseases.

Several facilities have been researching on next-generation gene sequencing on cancer research. However, Rutgers Cancer Institute was one of the Pioneer centers to dwell into genomic sequencing. The study allows the physician to diagnose the cancer type precisely.

Genomic sequencing approach to cancer treatment has been very helpful for patients with rare cancer type, those who had a poor prognosis and those whose treatment options had been limited or ineffective.

The sky will be the limit for the organization with more funding from people like Omar Boraie. Contributing to a good cause is always a welcome especially helping people with terminal illness.